Lukas E. Dow

11.9k total citations · 4 hit papers
73 papers, 6.0k citations indexed

About

Lukas E. Dow is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lukas E. Dow has authored 73 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 18 papers in Oncology and 18 papers in Genetics. Recurrent topics in Lukas E. Dow's work include CRISPR and Genetic Engineering (27 papers), Cancer Cells and Metastasis (11 papers) and Wnt/β-catenin signaling in development and cancer (11 papers). Lukas E. Dow is often cited by papers focused on CRISPR and Genetic Engineering (27 papers), Cancer Cells and Metastasis (11 papers) and Wnt/β-catenin signaling in development and cancer (11 papers). Lukas E. Dow collaborates with scholars based in United States, Australia and Germany. Lukas E. Dow's co-authors include Scott W. Lowe, Patrick O. Humbert, Emma M. Schatoff, Kevin P. O’Rourke, Darjus F. Tschaharganeh, Alyna Katti, Benjamin I. Leach, Sarah M. Russell, Ashlesha Muley and Hans Clevers and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Lukas E. Dow

72 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH

2015 696 citations Jihye Yun, Edouard Mullarky et al. Science profile →
Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer

2015 401 citations Lukas E. Dow, Kevin P. O’Rourke et al. profile →
CRISPR in cancer biology and therapy

2022 279 citations Alyna Katti, Bianca J. Diaz et al. profile →
Dietary fructose improves intestinal cell survival and nutrient absorption

2021 194 citations Alyna Katti, Emma M. Schatoff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lukas E. Dow United States	38	4.1k	1.3k	812	812	787	73	6.0k
Swadesh K. Das United States	44	3.2k 0.8×	1.6k 1.3×	667 0.8×	1.0k 1.3×	629 0.8×	153	6.3k
Nathalie Rivard Canada	39	2.8k 0.7×	1.2k 1.0×	562 0.7×	517 0.6×	575 0.7×	105	4.5k
Anne Hakem Canada	26	4.6k 1.1×	1.4k 1.1×	685 0.8×	986 1.2×	603 0.8×	36	6.1k
Kiyotsugu Yoshida Japan	40	4.0k 1.0×	1.5k 1.2×	439 0.5×	859 1.1×	430 0.5×	108	5.4k
Ningzhi Xu China	41	5.4k 1.3×	1.3k 1.0×	1.1k 1.4×	1.5k 1.8×	514 0.7×	158	7.4k
Teck Yew Low Malaysia	33	3.9k 1.0×	1.1k 0.9×	517 0.6×	528 0.7×	550 0.7×	88	5.6k
Stan Krajewski United States	44	3.7k 0.9×	857 0.7×	816 1.0×	635 0.8×	547 0.7×	74	5.7k
Kang‐Yell Choi South Korea	41	3.2k 0.8×	1.1k 0.8×	430 0.5×	601 0.7×	416 0.5×	143	4.7k
Ching-Shih Chen United States	46	3.3k 0.8×	920 0.7×	755 0.9×	652 0.8×	347 0.4×	83	5.3k
Maria Vittoria Barone Italy	39	2.3k 0.6×	919 0.7×	545 0.7×	392 0.5×	793 1.0×	120	4.8k

Countries citing papers authored by Lukas E. Dow

Since Specialization

Citations

This map shows the geographic impact of Lukas E. Dow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas E. Dow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas E. Dow more than expected).

Fields of papers citing papers by Lukas E. Dow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas E. Dow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas E. Dow. The network helps show where Lukas E. Dow may publish in the future.

Co-authorship network of co-authors of Lukas E. Dow

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas E. Dow. A scholar is included among the top collaborators of Lukas E. Dow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas E. Dow. Lukas E. Dow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murakami, Shino, Paul Zumbo, Lukas E. Dow, et al.. (2024). Selenocysteine tRNA methylation promotes oxidative stress resistance in melanoma metastasis. Nature Cancer. 5(12). 1868–1884. 6 indexed citations

Chu, Kevan & Lukas E. Dow. (2024). Adding New Dimensions to 3D Cancer Models. Cancer Research. 84(6). 798–799. 1 indexed citations

Pan, Chun‐Hao, Yan Yan, Rohit Thummalapalli, et al.. (2023). Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma. Cancer Discovery. 14(2). 308–325. 21 indexed citations

Mijn, Johannes C. van der, Kristian B. Laursen, Leiping Fu, et al.. (2023). Novel genetically engineered mouse models for clear cell renal cell carcinoma. Scientific Reports. 13(1). 8246–8246. 3 indexed citations

Katti, Alyna, Miguel Foronda, J. Lynn Zimmerman, et al.. (2023). Generation of precision preclinical cancer models using regulated in vivo base editing. Nature Biotechnology. 42(3). 437–447. 21 indexed citations

Huang, Chun‐Hao, Francisco J. Sánchez‐Rivera, Margaret C. Kennedy, et al.. (2022). A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets. Proceedings of the National Academy of Sciences. 119(17). e2110557119–e2110557119. 8 indexed citations

Kwong, Lawrence N., Teng Han, Michael T. Shanahan, et al.. (2022). Comprehensive microRNA analysis across genome-edited colorectal cancer organoid models reveals miR-24 as a candidate regulator of cell survival. BMC Genomics. 23(1). 792–792. 2 indexed citations

Arand, Julia, Alexandros P. Drainas, Yan Ting Shue, et al.. (2021). RB depletion is required for the continuous growth of tumors initiated by loss of RB. PLoS Genetics. 17(12). e1009941–e1009941. 5 indexed citations

Montrose, David C., Suchandrima Saha, Miguel Foronda, et al.. (2021). Exogenous and Endogenous Sources of Serine Contribute to Colon Cancer Metabolism, Growth, and Resistance to 5-Fluorouracil. Cancer Research. 81(9). 2275–2288. 82 indexed citations

10.

Ouchi, Takeshi, Sohshi Morimura, Lukas E. Dow, Hiroyuki Miyoshi, & Mark C. Udey. (2021). EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase. Cells. 10(2). 256–256. 12 indexed citations

11.

Hinze, Laura, Roxane Labrosse, Teng Han, et al.. (2020). Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy. Cancer Discovery. 10(11). 1690–1705. 43 indexed citations

12.

Zafra, María Paz, Marie J. Parsons, Direna Alonso‐Curbelo, et al.. (2020). An In Vivo Kras Allelic Series Reveals Distinct Phenotypes of Common Oncogenic Variants. Cancer Discovery. 10(11). 1654–1671. 71 indexed citations

13.

Katti, Alyna, Miguel Foronda, J. Lynn Zimmerman, et al.. (2020). GO: a functional reporter system to identify and enrich base editing activity. Nucleic Acids Research. 48(6). 2841–2852. 25 indexed citations

14.

Han, Teng, Sukanya Goswami, Yang Hu, et al.. (2020). Lineage Reversion Drives WNT Independence in Intestinal Cancer. Cancer Discovery. 10(10). 1590–1609. 46 indexed citations

15.

Schatoff, Emma M., Sukanya Goswami, María Paz Zafra, et al.. (2019). Distinct Colorectal Cancer–Associated APC Mutations Dictate Response to Tankyrase Inhibition. Cancer Discovery. 9(10). 1358–1371. 56 indexed citations

16.

Foronda, Miguel, Yusuke Tarumoto, Emma M. Schatoff, et al.. (2019). Tankyrase inhibition sensitizes cells to CDK4 blockade. PLoS ONE. 14(12). e0226645–e0226645. 3 indexed citations

17.

Song, Chun‐Qing, Tingting Jiang, Michelle F. Richter, et al.. (2019). Adenine base editing in an adult mouse model of tyrosinaemia. Nature Biomedical Engineering. 4(1). 125–130. 138 indexed citations

18.

Yun, Jihye, Edouard Mullarky, Kaitlyn Bosch, et al.. (2015). Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. 350(6266). 1391–1396. 696 indexed citations breakdown →

19.

Bolden, Jessica E., Nilgun Tasdemir, Lukas E. Dow, et al.. (2014). Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition. Cell Reports. 8(6). 1919–1929. 141 indexed citations

20.

Pearson, Helen, Pedro A. Pérez–Mancera, Lukas E. Dow, et al.. (2011). SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. Journal of Clinical Investigation. 121(11). 4257–4267. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact